Aliases & Classifications for Cerebral Hemorrhage

Aliases & Descriptions for Cerebral Hemorrhage:

Name: Cerebral Hemorrhage 38 29

Summaries for Cerebral Hemorrhage

MalaCards based summary : Cerebral Hemorrhage is related to cerebral amyloid angiopathy and cerebral amyloid angiopathy, dutch, italian, iowa, flemish, arctic variants, and has symptoms including angina pectoris, back pain and chest pain. An important gene associated with Cerebral Hemorrhage is CST3 (Cystatin C), and among its related pathways/superpathways are Neuroscience and Copper homeostasis. The drugs Heparin and Nicardipine have been mentioned in the context of this disorder. Affiliated tissues include brain, neutrophil and heart, and related phenotypes are homeostasis/metabolism and muscle

Related Diseases for Cerebral Hemorrhage

Diseases related to Cerebral Hemorrhage via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 119)
id Related Disease Score Top Affiliating Genes
1 cerebral amyloid angiopathy 11.9
2 cerebral amyloid angiopathy, dutch, italian, iowa, flemish, arctic variants 11.8
3 eclampsia 11.1
4 hemorrhage, intracerebral 10.8
5 thrombocytopenia, x-linked 10.7
6 cerebral cavernous malformations-1 10.7
7 cerebritis 10.6
8 amyloidosis 10.3
9 porencephaly 2 10.1 APP CST3
10 huntington disease-like 1 10.1 APP PRNP
11 measles 10.1 IL1B SOD1
12 early yaws 10.0 APP IL1B
13 ectodermal dysplasia bartalos type 10.0 IL1B SOD1
14 polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract 10.0 APP CST3 PRNP
15 histiocytoid hemangioma 10.0 IL1B SOD1
16 contagious pustular dermatitis 10.0 APP CST3 PRNP
17 hard palate cancer 10.0 APP CST3 PRNP
18 eumycotic mycetoma 10.0 APP CST3 PRNP
19 bone dysplasia azouz type 10.0 APP GFAP
20 vaginal spindle cell epithelioma 10.0 APP IL1B PRNP
21 cerebral folate receptor alpha deficiency 9.9 GFAP SOD1
22 deafness, autosomal recessive 101 9.9 GFAP PRNP
23 nasopharyngitis 9.9 IL1B SOD1
24 epileptic encephalopathy, early infantile, 1 9.9 CST3 GFAP
25 urea cycle disorder 9.9 GFAP IL1B
26 breast reconstruction 9.9 GFAP IL1B
27 baritosis 9.9 IL1B SOD1
28 syringocystadenoma papilliferum 9.8 APP GFAP PRNP
29 ovarian mucinous adenocarcinoma 9.8 GFAP IL1B PRNP
30 dementia 9.7
31 brain edema 9.6
32 endocarditis 9.6
33 alzheimer disease 9.6
34 encephalitis 9.6
35 hemophilia 9.6
36 infective endocarditis 9.6
37 moyamoya disease 9.6
38 thrombosis 9.6
39 neuronitis 9.6
40 brain injury 9.6
41 purpura 9.6
42 hereditary cerebral amyloid angiopathy 9.6
43 leukemia 9.6
44 aneurysm 9.6
45 nephrosclerosis 9.6
46 choriocarcinoma 9.6
47 traumatic brain injury 9.6
48 long qt syndrome 5 9.5 APP CST3 GFAP PRNP SOD1
49 substance-induced psychosis 9.4 APP GFAP IL1B PRNP SOD1
50 epithelioid type angiomyolipoma 9.4 APP GFAP IL1B PRNP SOD1

Graphical network of the top 20 diseases related to Cerebral Hemorrhage:



Diseases related to Cerebral Hemorrhage

Symptoms & Phenotypes for Cerebral Hemorrhage

UMLS symptoms related to Cerebral Hemorrhage:


angina pectoris, back pain, chest pain, edema, headache, pain, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Cerebral Hemorrhage:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.63 SOD1 APP CST3 GFAP IL1B PRNP
2 muscle MP:0005369 9.35 APP CST3 GFAP PRNP SOD1
3 nervous system MP:0003631 9.1 APP CST3 GFAP IL1B PRNP SOD1

Drugs & Therapeutics for Cerebral Hemorrhage

Drugs for Cerebral Hemorrhage (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 619)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
2
Nicardipine Approved Phase 4,Phase 3,Phase 2,Phase 1 55985-32-5 4474
3
Dalteparin Approved Phase 4,Phase 3,Phase 2 9041-08-1
4 Nadroparin Approved Phase 4 9041-08-1
5
Clevidipine Approved Phase 4,Phase 3,Phase 2 167221-71-8
6
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-78-2 2244
7
Acetaminophen Approved Phase 4,Phase 3,Phase 1,Early Phase 1 103-90-2 1983
8
Ibuprofen Approved Phase 4,Phase 1,Phase 2 15687-27-1 3672
9
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
10
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
11
Zinc Approved Phase 4,Phase 3 7440-66-6 32051 23994
12
Nimodipine Approved Phase 4,Phase 3,Phase 1,Phase 2 66085-59-4 4497
13
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 55142-85-3 5472
14
Tranexamic Acid Approved Phase 4,Phase 3,Phase 2 1197-18-8 5526
15
Tirofiban Approved Phase 4 144494-65-5 60947
16 Piracetam Approved Phase 4,Phase 3 7491-74-9
17
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
18
Propranolol Approved, Investigational Phase 4 525-66-6 4946
19
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 50-28-2 5757 53477783
20
Mannitol Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 69-65-8 453 6251
21
Warfarin Approved Phase 4,Phase 3,Phase 2,Phase 1 81-81-2 6691 54678486
22
Ethanol Approved Phase 4,Phase 1,Phase 2 64-17-5 702
23
Magnesium Sulfate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 7487-88-9 24083
24
Argatroban Approved, Investigational Phase 4,Phase 2,Phase 1 74863-84-6 152951
25
Cilostazol Approved Phase 4,Phase 3,Phase 2 73963-72-1 2754
26
Lactulose Approved Phase 4,Phase 3 4618-18-2 11333
27
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
28
Histamine Approved, Investigational Phase 4,Phase 2 75614-87-8, 51-45-6 774
29
Nitroglycerin Approved, Investigational Phase 4,Phase 2 55-63-0 4510
30
Rivaroxaban Approved Phase 4,Phase 2,Phase 3 366789-02-8
31
Dexmedetomidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 76631-46-4, 113775-47-6 68602 5311068 56032
32
Iron Approved Phase 4,Phase 1,Phase 2,Early Phase 1 7439-89-6 23925
33 Edoxaban Approved Phase 4,Phase 2,Phase 3 480449-70-5
34
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754 657311
35
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
36
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
37
Valproic Acid Approved, Investigational Phase 4,Phase 1,Phase 2 99-66-1 3121
38
Amlodipine Approved Phase 4 88150-42-9 2162
39
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
40
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 6366718 5282452
41
Desflurane Approved Phase 4 57041-67-5 42113
42
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
43
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 2078-54-8 4943
44
Fosphenytoin Approved Phase 4 93390-81-9 56339
45
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
46
Pravastatin Approved Phase 4 81093-37-0 54687
47
Dipyridamole Approved Phase 4,Phase 3,Phase 2 58-32-2 3108
48
Antipyrine Approved Phase 4 60-80-0 2206
49
Rifaximin Approved, Investigational Phase 4,Phase 3 80621-81-4 6436173
50
Apixaban Approved Phase 4,Phase 3,Phase 2 503612-47-3 10182969

Interventional clinical trials:

(show top 50) (show all 1176)
id Name Status NCT ID Phase
1 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4
2 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4
3 Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD Unknown status NCT01531829 Phase 4
4 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Unknown status NCT01042574 Phase 4
5 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4
6 The Role of Statins in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage Unknown status NCT01346748 Phase 4
7 Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage Unknown status NCT01530880 Phase 4
8 Normothermia in Patients With Acute Cerebral Damage Unknown status NCT00491192 Phase 4
9 Normoglycemia and Neurological Outcome Unknown status NCT01137773 Phase 4
10 Nimodipine for Treating Acute Massive Cerebral Infarction Unknown status NCT02248233 Phase 4
11 Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy Unknown status NCT00505505 Phase 4
12 Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting Unknown status NCT01572623 Phase 4
13 Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma? Unknown status NCT01470040 Phase 4
14 Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke Unknown status NCT01862978 Phase 4
15 TXA in the EMS on the Helicopter and the Ambulance Unknown status NCT02354885 Phase 4
16 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4
17 NIMIP: Non Invasive Measurement of the Intracranial Pressure Unknown status NCT01685450 Phase 4
18 Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease Unknown status NCT02294994 Phase 4
19 Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study Unknown status NCT01935908 Phase 4
20 Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Unknown status NCT02126202 Phase 4
21 Japanese Primary Prevention Project With Aspirin Unknown status NCT00225849 Phase 4
22 Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal Unknown status NCT01059396 Phase 4
23 Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives. Unknown status NCT01251263 Phase 4
24 HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data Study Unknown status NCT01516658 Phase 4
25 Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects Unknown status NCT00799045 Phase 4
26 Seizures Post Intracerebral Hemorrhage Completed NCT01115959 Phase 4
27 Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin Completed NCT02999048 Phase 4
28 International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage Completed NCT00928915 Phase 4
29 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4
30 Temperature Control in Central Fever in the Neuro-ICU Completed NCT00751634 Phase 4
31 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Completed NCT00809055 Phase 4
32 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System Completed NCT00197392 Phase 4
33 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4
34 Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study Completed NCT00839449 Phase 4
35 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
36 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Completed NCT00301392 Phase 4
37 Comparison of Neuroprotection by Propofol and Desflurane for POCD Following Subarachnoid Hemorrhage Surgery Completed NCT02987218 Phase 4
38 Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment Completed NCT00386191 Phase 4
39 Inhalatorial Sedation in Patient With Subarachnoid Hemorrhage (SAH) Versus Conventional Intravenous Sedation Completed NCT00830843 Phase 4
40 Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention Completed NCT00618436 Phase 4
41 Phase IV Bioseal Study in Brain Tumor Surgery Completed NCT02034799 Phase 4
42 Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth Completed NCT00120588 Phase 4
43 Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Japan Alteplase Clinical Trial Ⅱ:J-ACT Ⅱ) Completed NCT00412867 Phase 4
44 Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel Completed NCT00405717 Phase 4
45 ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial Completed NCT00161070 Phase 4
46 Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke Completed NCT00153946 Phase 4
47 Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention Completed NCT00404781 Phase 4
48 Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding Completed NCT02158182 Phase 4
49 NIMI-NICU: Non Invasive Monitoring of the Intracranial Pressure - NeuroIntensive Care Unit Completed NCT01685476 Phase 4
50 Overcome Biochemical Aspirin Resistance Through Cilostazol Combination Completed NCT00446641 Phase 4

Search NIH Clinical Center for Cerebral Hemorrhage

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Cerebral Hemorrhage cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Cerebral Hemorrhage:
GLP-1 CellBeads
Embryonic/Adult Cultured Cells Related to Cerebral Hemorrhage:
GLP-transfected mesenchymal stem cells PMIDs: 22985173 22034462

Genetic Tests for Cerebral Hemorrhage

Genetic tests related to Cerebral Hemorrhage:

id Genetic test Affiliating Genes
1 Cerebral Hemorrhage 29

Anatomical Context for Cerebral Hemorrhage

MalaCards organs/tissues related to Cerebral Hemorrhage:

39
Brain, Neutrophil, Heart, Lung, T Cells, Liver, Pituitary

Publications for Cerebral Hemorrhage

Articles related to Cerebral Hemorrhage:

(show top 50) (show all 233)
id Title Authors Year
1
Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. ( 28356458 )
2017
2
Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy. ( 28090058 )
2017
3
Cerebral hemorrhage in monozygotic twins with hereditary hemorrhagic telangiectasia: case report and hemorrhagic risk evaluation. ( 28524787 )
2017
4
Contrast extravasation through MRI precedes cerebral hemorrhage in a patient with eclampsia. ( 27885447 )
2016
5
Nao-Xue-Shu Oral Liquid Protects and Improves Secondary Brain Insults of Hypertensive Cerebral Hemorrhage. ( 27110267 )
2016
6
Cerebral Hemorrhage Following Chiropractic Activator Treatment - Case Report and Review of Literature. ( 27999766 )
2016
7
The correlation between blood calcium level, hematoma volume, stroke severity and prognosis in patients with acute cerebral hemorrhage. ( 27775786 )
2016
8
Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results. ( 27143274 )
2016
9
Spontaneous Cerebral Hemorrhage and Sudden Biventricular Failure After Lung Transplantation. ( 27654933 )
2016
10
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. ( 27276234 )
2016
11
Blood pressure in acute intra-cerebral hemorrhage. ( 27668240 )
2016
12
Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies. ( 27165954 )
2016
13
Application values of clinical nursing pathway in patients with acute cerebral hemorrhage. ( 26893635 )
2016
14
Comprehensive endovascular treatment of multiple arterial emboli involving LIMA graft, distal aorta and upper and lower extremities in a patient with subacute cerebral hemorrhage. ( 27832336 )
2016
15
The effects of MCA-MAO on cAMP pathway in rats with cerebral hemorrhage. ( 27212177 )
2016
16
"Timing" of arrival and in-hospital mortality in a cohort of patients under anticoagulant therapy presenting to the emergency departments with cerebral hemorrhage: A multicenter chronobiological study in Italy. ( 26852790 )
2016
17
Foxo1-mediated inflammatory response after cerebral hemorrhage in rats. ( 27288017 )
2016
18
A Randomized Clinical Trial of Aggressive Blood Pressure Control in Patients With Acute Cerebral Hemorrhage. ( 27861410 )
2016
19
Association of protein Z and factor VII gene polymorphisms with risk of cerebral hemorrhage: a case-control and a family-based association study in a Chinese Han population. ( 27350683 )
2016
20
Relationship of plasma matrix metalloproteinase-9 andA hematoma expansion in acute hypertensive cerebral hemorrhage. ( 26708160 )
2016
21
HSV-2 encephalitis complicated by cerebral hemorrhage in an immunocompetent person. ( 26878968 )
2016
22
Design and Rationale for a Cognitive Outcome Substudy in Ischemic Stroke Patients with High Risk of Cerebral Hemorrhage. ( 27263034 )
2016
23
[Association of CETP gene I405V/D442G polymorphisms with cerebral hemorrhage and serum lipid profile in ethnic Han population from Changsha]. ( 26829743 )
2016
24
Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. ( 27959682 )
2016
25
Endoscope-Assisted Keyhole Technique for Hypertensive Cerebral Hemorrhage in Elderly Patients: A Randomized Controlled Study in 184 Patients. ( 26768873 )
2016
26
Clinical Features of Liver Cancer with Cerebral Hemorrhage. ( 27209058 )
2016
27
Guillain-BarrAc Syndrome and Cerebral Hemorrhage: Two Cases and Literature Review. ( 27669485 )
2016
28
Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke. ( 27018013 )
2016
29
The protective and hemodynamic effects of dexmedetomidine on hypertensive cerebral hemorrhage patients in the perioperative period. ( 27882094 )
2016
30
Adjuvant-induced mono-arthritis potentiates cerebral hemorrhage in the spontaneously hypertensive rats. ( 26903291 )
2016
31
Intensive Blood-Pressure Lowering in Cerebral Hemorrhage. ( 27959683 )
2016
32
Methanol intoxication with cerebral hemorrhage. ( 27356664 )
2016
33
Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies. ( 26958746 )
2016
34
Unusual Initial Manifestation of Acquired Hemophilia A: A Normal Activated Partial Thromboplastin Time, Intramuscular Hematoma and Cerebral Hemorrhage. ( 27853081 )
2016
35
Choriocarcinoma of unknown origin with multiple organ metastasis and cerebral hemorrhage: A case report and literature review. ( 27313687 )
2016
36
Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1). ( 27491738 )
2016
37
Dengue fever with diffuse cerebral hemorrhages, subdural hematoma and cranial diabetes insipidus. ( 27165581 )
2016
38
Clinical effect of minimally invasive intracranial hematoma in treating hypertensive cerebral hemorrhage. ( 27375713 )
2016
39
Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease. ( 26836195 )
2016
40
Lower hazard ratio for death in women with cerebral hemorrhage. ( 25643895 )
2015
41
505: PATTERNS OF CEREBRAL HEMORRHAGE AND INFARCTION COMPLICATING PEDIATRIC ECMO. ( 26570166 )
2015
42
Letter by turc et Al regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials". ( 25572409 )
2015
43
Expression of transferrin in hematoma brain tissue at different stages after intra cerebral hemorrhage in rats. ( 26276291 )
2015
44
Significance of intraventricular hemorrhage in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial results. ( 25677598 )
2015
45
Prognostic significance of perihematomal edema in acute intracerebral hemorrhage: pooled analysis from the intensive blood pressure reduction in acute cerebral hemorrhage trial studies. ( 25712944 )
2015
46
Effects of platelet infusion, anticoagulant and other risk factors on the rehaemorrhagia after surgery of hypertensive cerebral hemorrhage. ( 25807432 )
2015
47
Contrast extravasation mimics cerebral hemorrhage in acute ischemic stroke after Solitaire FR clot retrieval and intraarterial thrombolysis: a case report. ( 25944512 )
2015
48
Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier. ( 26661252 )
2015
49
Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial. ( 26044566 )
2015
50
A new method to image heme-Fe, total Fe and aggregated protein levels after intra-cerebral hemorrhage. ( 25695130 )
2015

Variations for Cerebral Hemorrhage

Expression for Cerebral Hemorrhage

Search GEO for disease gene expression data for Cerebral Hemorrhage.

Pathways for Cerebral Hemorrhage

Pathways related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.53 APP CST3 GFAP PRNP SOD1
2 11.06 APP PRNP SOD1
3 10.74 APP CST3
4 10.68 IL1B PRNP SOD1
5 10.67 APP PRNP

GO Terms for Cerebral Hemorrhage

Cellular components related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 secretory granule GO:0030141 8.96 IL1B SOD1
2 lysosome GO:0005764 8.92 CST3 GFAP IL1B SOD1

Biological processes related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 locomotory behavior GO:0007626 9.51 APP SOD1
2 cellular response to oxidative stress GO:0034599 9.49 CST3 SOD1
3 cellular response to drug GO:0035690 9.48 IL1B PRNP
4 response to nutrient levels GO:0031667 9.46 CST3 SOD1
5 learning or memory GO:0007611 9.43 APP PRNP
6 response to axon injury GO:0048678 9.4 CST3 SOD1
7 regulation of multicellular organism growth GO:0040014 9.37 APP SOD1
8 response to copper ion GO:0046688 9.32 PRNP SOD1
9 cellular copper ion homeostasis GO:0006878 9.26 APP PRNP
10 response to carbohydrate GO:0009743 9.16 CST3 IL1B
11 embryo implantation GO:0007566 9.13 CST3 IL1B SOD1
12 response to oxidative stress GO:0006979 8.92 APP CST3 PRNP SOD1

Molecular functions related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chaperone binding GO:0051087 9.26 PRNP SOD1
2 copper ion binding GO:0005507 9.16 PRNP SOD1
3 identical protein binding GO:0042802 9.02 APP CST3 GFAP PRNP SOD1
4 beta-amyloid binding GO:0001540 8.96 CST3 PRNP

Sources for Cerebral Hemorrhage

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....